02.02.2013 Views

Proceedings of the 10th International Colloquium on Paratuberculosis

Proceedings of the 10th International Colloquium on Paratuberculosis

Proceedings of the 10th International Colloquium on Paratuberculosis

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

#19 Development <str<strong>on</strong>g>of</str<strong>on</strong>g> a multiplex PCR assay targeting IS900 and F57 genes in <str<strong>on</strong>g>the</str<strong>on</strong>g> diagnosis <str<strong>on</strong>g>of</str<strong>on</strong>g><br />

paratuberculosis<br />

Bhupendra N. Tripathi, R B Bind, Ganesh G S<strong>on</strong>awane, S K Munjal, Karen Stevens<strong>on</strong>, Shirish Narnaware,<br />

Biplab Debroy<br />

Indian Veterinary Research Institute, Izatnagar India; Central Sheep and Wool Research Institute,<br />

Awikanagar, Rajsthan, India<br />

The objective <str<strong>on</strong>g>of</str<strong>on</strong>g> <str<strong>on</strong>g>the</str<strong>on</strong>g> study was to develop a PCR simultaneously amplifying two genes IS900 and F57 for identifying<br />

and c<strong>on</strong>firming <str<strong>on</strong>g>the</str<strong>on</strong>g> presence <str<strong>on</strong>g>of</str<strong>on</strong>g> Mycobacterium avium subsp. paratuberculosis (MAP) in clinical samples<br />

from animals. This could avoid subsequent c<strong>on</strong>firmati<strong>on</strong> <str<strong>on</strong>g>of</str<strong>on</strong>g> PCR products in light <str<strong>on</strong>g>of</str<strong>on</strong>g> <str<strong>on</strong>g>the</str<strong>on</strong>g> questi<strong>on</strong>able specificity<br />

<str<strong>on</strong>g>of</str<strong>on</strong>g> <str<strong>on</strong>g>the</str<strong>on</strong>g> IS900 gene. Two specific primer sets; <strong>on</strong>e from IS900 and o<str<strong>on</strong>g>the</str<strong>on</strong>g>r from F57 genes were used for <str<strong>on</strong>g>the</str<strong>on</strong>g> amplificati<strong>on</strong><br />

<str<strong>on</strong>g>of</str<strong>on</strong>g> 314 bp and 439 bp PCR products, respectively. The DNA samples used in <str<strong>on</strong>g>the</str<strong>on</strong>g> multiplex PCR were<br />

extracted from tissues and MAP isolates maintained in <str<strong>on</strong>g>the</str<strong>on</strong>g> Johne’s disease laboratory (GD Lab.) using standard<br />

protocols. The PCR was applied to high quality DNA from 52 MAP, 5 n<strong>on</strong>-MAP isolates from various hosts<br />

and geographic origins and 45 fresh intestinal tissue samples from infected sheep and goats and suspected<br />

cases <str<strong>on</strong>g>of</str<strong>on</strong>g> bovine paratuberculosis. All MAP isolates (100%) were positive for both genes and all 5 n<strong>on</strong>-MAP isolates<br />

were negative for both genes. Twenty six out <str<strong>on</strong>g>of</str<strong>on</strong>g> 30 goat tissue samples and 6 <str<strong>on</strong>g>of</str<strong>on</strong>g> 8 sheep samples yielded<br />

amplificati<strong>on</strong> <str<strong>on</strong>g>of</str<strong>on</strong>g> both genes, whereas <strong>on</strong>ly IS900 was amplified from 4 goat and 2 sheep samples and <strong>on</strong>e <str<strong>on</strong>g>of</str<strong>on</strong>g> 7<br />

suspected cases <str<strong>on</strong>g>of</str<strong>on</strong>g> bovine paratuberculosis. These samples probably c<strong>on</strong>tained low numbers <str<strong>on</strong>g>of</str<strong>on</strong>g> MAP which<br />

could be detected <strong>on</strong>ly by PCR directed against a multicopy gene such as IS900. The results <str<strong>on</strong>g>of</str<strong>on</strong>g> <str<strong>on</strong>g>the</str<strong>on</strong>g> present<br />

study suggested that while multiplex PCR could be used for identificati<strong>on</strong> and c<strong>on</strong>firmati<strong>on</strong> <str<strong>on</strong>g>of</str<strong>on</strong>g> MAP isolates,<br />

a minority <str<strong>on</strong>g>of</str<strong>on</strong>g> clinical samples may be positive for <strong>on</strong>ly <str<strong>on</strong>g>the</str<strong>on</strong>g> IS900 gene and additi<strong>on</strong>al tests may be required to<br />

c<strong>on</strong>firm a diagnosis <str<strong>on</strong>g>of</str<strong>on</strong>g> Johne’s disease in <str<strong>on</strong>g>the</str<strong>on</strong>g>se animals.<br />

#29 C<strong>on</strong>ductometric biosensor for diagnosis <str<strong>on</strong>g>of</str<strong>on</strong>g> Johne’s disease<br />

Chika C Okafor, Daniel L Grooms, Evangelyn C Alocilja, Steven R Bolin<br />

Michigan State University, USA<br />

The development <str<strong>on</strong>g>of</str<strong>on</strong>g> n<strong>on</strong>-laboratory based assays would support more frequent testing <str<strong>on</strong>g>of</str<strong>on</strong>g> animals for Johnes<br />

disease (JD) and could improve its c<strong>on</strong>trol. Newly developed c<strong>on</strong>ductometric biosensors combine immunomigrati<strong>on</strong><br />

technology with electr<strong>on</strong>ic signal detecti<strong>on</strong> and has been recently developed for <str<strong>on</strong>g>the</str<strong>on</strong>g> detecti<strong>on</strong> <str<strong>on</strong>g>of</str<strong>on</strong>g> Mycobacterium<br />

avium subsp. paratubercolosis (MAP) IgG. Optimizati<strong>on</strong> <str<strong>on</strong>g>of</str<strong>on</strong>g> this biosensor is needed to support<br />

its usefulness in diagnosis. In this study, two aspects <str<strong>on</strong>g>of</str<strong>on</strong>g> <str<strong>on</strong>g>the</str<strong>on</strong>g> previously developed c<strong>on</strong>ductometric biosensor<br />

were optimized for its applicati<strong>on</strong> in JD diagnosis. After optimizati<strong>on</strong>, a pilot study <strong>on</strong> <str<strong>on</strong>g>the</str<strong>on</strong>g> biosensor’s use in JD<br />

diagnosis was c<strong>on</strong>ducted, using samples whose JD status where unknown. A commercially available antibody<br />

detecti<strong>on</strong> ELISA was used as a gold standard for comparis<strong>on</strong>. The biosensor’s sensitivity was (71.43%) and<br />

specificity (70%) when compared to <str<strong>on</strong>g>the</str<strong>on</strong>g> antibody detecti<strong>on</strong> ELISA. There was a moderate strength <str<strong>on</strong>g>of</str<strong>on</strong>g> agreement<br />

(Kappa = 0.41) between <str<strong>on</strong>g>the</str<strong>on</strong>g> two assays. Findings from this study support <str<strong>on</strong>g>the</str<strong>on</strong>g> c<strong>on</strong>tinued development <str<strong>on</strong>g>of</str<strong>on</strong>g><br />

c<strong>on</strong>ductometric biosensors for use in <str<strong>on</strong>g>the</str<strong>on</strong>g> diagnosis <str<strong>on</strong>g>of</str<strong>on</strong>g> JD. Fur<str<strong>on</strong>g>the</str<strong>on</strong>g>r optimizati<strong>on</strong> <str<strong>on</strong>g>of</str<strong>on</strong>g> <str<strong>on</strong>g>the</str<strong>on</strong>g> biosensor and validati<strong>on</strong><br />

with a larger sample size could support its use in JD c<strong>on</strong>trol programs.<br />

49

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!